Monitor for selling by the three noteholder selling stockholders, who collectively could sell up to 500,000 shares. The stock's high volatility (11.8% normal daily move) and low market cap ($19M) mean even partial selling could pressure the price. The company's need for further capital (given NYSE non-compliance and going concern) may lead to additional dilutive financing.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $9.00entry
- T+1 · 8d ago −6.22%α −8.59% · $8.44
- T+5 · 4d ago −19.67%α −22.26% · $7.23
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Picard Medical filed Amendment No. 1 to its S-3 registration statement to register up to 500,000 shares of common stock for resale by selling stockholders. These shares are issuable upon conversion of $1.0 million in convertible notes issued on September 30, 2026, and upon exercise of related pre-funded warrants. The company will not receive any proceeds from the resale, but the registration enables potential near-term selling by noteholders, adding overhang to a stock with a $19M market cap and 2.46M shares outstanding.
Key Financial Metrics
Key Facts
- Registers up to 500,000 shares for resale by three selling stockholders (Fengjun Xue, Xiangdie Liu, Xiangyang Xu).
- Shares consist of up to 250,000 shares issuable upon conversion of $1.0M convertible notes (3% interest, floor price $4.00) and up to 250,000 shares issuable upon exercise of pre-funded warrants at $0.0001 per share.
- Convertible notes were issued on September 30, 2026; warrants are exercisable 60 days after issuance and expire in two years.
- Company will not receive any proceeds from the resale.
- As of October 13, 2026, there were 2,458,574 shares outstanding; full conversion and exercise would increase that to 2,958,574 shares (20.3% dilution).
- Market cap is $19M; the $1.0M note principal represents ~5.3% of market cap.
- Company is non-compliant with NYSE American stockholders' equity rule (reported $3.8M equity as of Dec 31, 2025) and has an accepted compliance plan with a deadline of November 8, 2027.
- Company has a history of frequent capital raises: 19 offering/registration filings in the last 24 months.
- Auditor's report on 2025 financials includes a going concern explanatory paragraph.
Financial Impact
Potential dilution of 20.3% (500,000 new shares vs 2,458,574 outstanding). The $1.0M convertible note principal is 5.3% of the $19M market cap.
Risk Factors
- Potential overhang from resale of up to 500,000 shares (20.3% of current outstanding).
- Company is not receiving any proceeds from this registration, so it does not address its capital needs.
- NYSE American non-compliance for stockholders' equity remains unresolved; failure to regain compliance by November 8, 2027 could lead to delisting.
- Auditor's going concern qualification indicates risk of insufficient capital.
- Frequent past equity raises (19 filings in 24 months) suggest ongoing cash burn.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001437749-26-035285 |
| Document: 0001437749-26-035285-index-headers.html | 0001437749-26-035285 |
| Document: 0001437749-26-035285-index.html | 0001437749-26-035285 |
| Document: 0001437749-26-035285.txt | 0001437749-26-035285 |
Track record
27 reports on PMI
5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +138.72% at T+60 after the Jul 27, 2026 report. 11 of 13 went positive at some point.
Filters
- Nov 16, 2026today Press Release Bearish 6/10 Entry $7.24 Now $7.24 +0.00% settles Feb 16
- Nov 12, 20265d ago EFFECT Bearish 5/10 Entry $7.85 Now $7.24 +7.77% settles Feb 10
- Nov 5, 202611d ago S-3/A Bearish 5/10 Viewing Entry $9.00 Now $7.24 +19.56% settles Feb 4
- Nov 3, 202613d ago 8-K Bearish 5/10 Entry $7.19 Now $7.24 −0.70% settles Feb 2
- Oct 23, 202624d ago 8-K Mixed 5/10 Entry $6.43 Now $7.24 +12.60% settles Jan 22
- Oct 22, 202625d ago S-3 Bearish 6/10 Entry $7.37 Now $7.24 +1.76% settles Jan 20
- Oct 6, 20265w ago 8-K Bearish 6/10 Entry $8.74 Now $7.24 +17.16% settles Dec 31
- Jul 27, 202616w ago 8-K Bullish 6/10 Entry $0.0878 to $0.2096 Now $7.24 +8146.01% ▲ +138.72% +134.67% vs SPY
- Jul 15, 202617w ago DEFA14A Neutral 2/10 Entry $0.1600 to $0.1896 Now $7.24 +4425.00% ▲ +18.50% +14.79% vs SPY
- Jul 8, 202618w ago DEFA14A Neutral 2/10 Entry $0.1500 to $0.0864 Now $7.24 +4726.67% ▼ −42.40% −44.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers